Nov 18 (Reuters) - Johnson & Johnson's (JNJ.N), opens new tab oral drug for a type of skin condition met ... hustling for a ...

Nektar Therapeutics Presents First Preclinical Data from Novel CSF-1 Program, NKTR-422, at 2024 American College of Rheumatology (ACR) Convergence ...

Researchers have developed a new class of oral painkillers to suppress chronic abdominal pain that is based on the peptide hormone oxytocin that drives childbirth contractions.

The oral medication muvalaplin may safely lower high levels of lipoprotein(a), also known as Lp(a), an independent, inherited risk factor for cardiovascular disease. Muvalaplin is a small molecule ...

Some antibiotics can cause a yeast infection. Learn more about how antibiotics cause yeast infections, risk factors for yeast infections, and how to treat and prevent them.

At baseline eligible patients were permitted to be receiving stable doses of concomitant medications for recurrent pericarditis (non-steroidal anti-inflammatory drugs and/or colchicine and/or oral ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...

The bacterial changes also correlate with increased antibiotic resistance, highlighting the need for better targeting of ...

A study testing a new nasal spray form of the medication bumetanide, a commonly prescribed diuretic, was found to be as safe ...

People who take an anticoagulant medicine double their risk of an internal bleed if they take a type of painkiller called a ...

Oral presentation at ACR highlights safety and efficacy data from the Phase 1 trial of umbilical cord outer lining-derived stem cells (ULSCs) ...

LUNA data combined with follow-up from OPTIC at 4 years continue to support long-term potential best-in-class product profile of ...